These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Proprostate-specific antigen: its usefulness in the era of multiple-core prostate biopsy. Miyakubo M; Ito K; Yamamoto T; Takechi H; Ohi M; Suzuki K Int J Urol; 2009 Jun; 16(6):561-5. PubMed ID: 19456991 [TBL] [Abstract][Full Text] [Related]
6. Preoperative serum sex hormone-binding globulin as a predictive marker for extraprostatic extension of tumor in patients with clinically localized prostate cancer. Lee SE; Chung JS; Han BK; Park CS; Moon KH; Byun SS; Choe G; Hong SK Eur Urol; 2008 Dec; 54(6):1324-32. PubMed ID: 18339472 [TBL] [Abstract][Full Text] [Related]
7. Value of prostate-specific antigen and prostate-specific antigen density in detection of prostate cancer in an Iranian population of men. Ghafoori M; Varedi P; Hosseini SJ; Asgari M; Shakiba M Urol J; 2009; 6(3):182-8. PubMed ID: 19711272 [TBL] [Abstract][Full Text] [Related]
8. Complexed prostate specific antigen: better test in the diagnosis of prostate cancer for the clinically relevant 2.5-4 ng/ml total PSA range. Mutlu N; Türkeri LN; Yencilek F; Demir A; Emerk K Can J Urol; 2009 Apr; 16(2):4558-67. PubMed ID: 19364428 [TBL] [Abstract][Full Text] [Related]
9. Comparison of 6- and 12-core prostate biopsy in Taiwanese men: impact of total prostate-specific antigen, prostate-specific antigen density and prostate volume on prostate cancer detection. Chiang IN; Chang SJ; Pu YS; Huang KH; Yu HJ; Huang CY Urol Int; 2009; 82(3):270-5. PubMed ID: 19440012 [TBL] [Abstract][Full Text] [Related]
10. Conformal radiotherapy for detectable PSA following radical prostatectomy: efficacy and predictive factors of recurrence. Delongchamps NB; Zerbib M; Mejean A; Rouach Y; Debre B; Peyromaure M Can J Urol; 2009 Oct; 16(5):4813-9. PubMed ID: 19796456 [TBL] [Abstract][Full Text] [Related]
11. Benign prostatic hyperplasia-associated free prostate-specific antigen improves detection of prostate cancer in an artificial neural network. Stephan C; Cammann H; Deger S; Schrader M; Meyer HA; Miller K; Lein M; Jung K Urology; 2009 Oct; 74(4):873-7. PubMed ID: 19476981 [TBL] [Abstract][Full Text] [Related]
12. Correction of prostate-specific antigen velocity for variation may improve prediction of cancer following prostate repeat biopsy. Kumar A; Godoy G; Taneja SS Can J Urol; 2009 Jun; 16(3):4655-9. PubMed ID: 19497172 [TBL] [Abstract][Full Text] [Related]
13. Predictive value of prostate-specific antigen expression in prostate cancer: a tissue microarray study. Erbersdobler A; Isbarn H; Steiner I; Schlomm T; Chun F; Mirlacher M; Sauter G Urology; 2009 Nov; 74(5):1169-73. PubMed ID: 19476978 [TBL] [Abstract][Full Text] [Related]
14. External validation of the updated Partin tables in a cohort of North American men. Karakiewicz PI; Bhojani N; Capitanio U; Reuther AM; Suardi N; Jeldres C; Pharand D; Péloquin F; Perrotte P; Shariat SF; Klein EA J Urol; 2008 Sep; 180(3):898-902; discussion 902-3. PubMed ID: 18635222 [TBL] [Abstract][Full Text] [Related]
15. Perineural invasion is a prognostic factor for biochemical failure after radical prostatectomy. Jeon HG; Bae J; Yi JS; Hwang IS; Lee SE; Lee E Int J Urol; 2009 Aug; 16(8):682-6. PubMed ID: 19602004 [TBL] [Abstract][Full Text] [Related]
16. External validation of a laparoscopic-based score to evaluate resectability of advanced ovarian cancers: clues for a simplified score. Brun JL; Rouzier R; Uzan S; Daraï E Gynecol Oncol; 2008 Sep; 110(3):354-9. PubMed ID: 18572226 [TBL] [Abstract][Full Text] [Related]
17. Body mass index and prostate specific antigen as predictors of adverse pathology and biochemical recurrence after prostatectomy. Bañez LL; Sun L; Trock BJ; Han M; Partin AW; Aronson WJ; Terris MK; Presti JC; Kane CJ; Amling CL; Moul JW; Freedland SJ J Urol; 2009 Aug; 182(2):491-6; discussion 496-8. PubMed ID: 19524974 [TBL] [Abstract][Full Text] [Related]
18. [Protein of type 1 binding insulin-like growth factors in blood serum in cancer and prostatic adenoma]. Morozov AP; Trapeznikov MF; Kushlinskiĭ NE Urologiia; 2007; (2):50-3. PubMed ID: 17580387 [TBL] [Abstract][Full Text] [Related]
19. Clinical assessment of the cancer diagnostic value of prostatic zinc: a comprehensive needle-biopsy study. Cortesi M; Fridman E; Volkov A; Shilstein SSh; Chechik R; Breskin A; Vartsky D; Kleinman N; Kogan G; Moriel E; Gladysh V; Huszar M; Ramon J; Raviv G Prostate; 2008 Jun; 68(9):994-1006. PubMed ID: 18386292 [TBL] [Abstract][Full Text] [Related]
20. Annexin A3 in urine: a highly specific noninvasive marker for prostate cancer early detection. Schostak M; Schwall GP; Poznanović S; Groebe K; Müller M; Messinger D; Miller K; Krause H; Pelzer A; Horninger W; Klocker H; Hennenlotter J; Feyerabend S; Stenzl A; Schrattenholz A J Urol; 2009 Jan; 181(1):343-53. PubMed ID: 19012935 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]